News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
30,495 Results
Type
Article (2569)
Company Profile (9)
Press Release (27917)
Multimedia
Podcasts (5)
Webinars (2)
Section
Business (10031)
Career Advice (96)
Deals (1076)
Drug Delivery (4)
Drug Development (2645)
Employer Resources (3)
FDA (490)
Job Trends (647)
News (14335)
Policy (1028)
Tag
Academia (393)
Academic (1)
Adcomms (1)
Allergies (4)
Alliances (3519)
ALS (1)
Alzheimer's disease (45)
Antibody-drug conjugate (ADC) (4)
Approvals (492)
Artificial intelligence (20)
Automation (1)
Bankruptcy (13)
Best Places to Work (463)
BIOSECURE Act (2)
Biotechnology (6)
Bladder cancer (1)
Brain cancer (1)
Breast cancer (9)
Cancer (89)
Cardiovascular disease (8)
Career advice (85)
Career pathing (3)
CAR-T (9)
CDC (2)
Cell therapy (27)
Cervical cancer (1)
Clinical research (2007)
Collaboration (99)
Compensation (6)
Complete response letters (1)
COVID-19 (248)
CRISPR (13)
C-suite (34)
Cystic fibrosis (3)
Data (125)
Decentralized trials (1)
Denatured (4)
Depression (1)
Diabetes (8)
Diagnostics (352)
Diversity, equity & inclusion (1)
Drug discovery (21)
Drug pricing (6)
Duchenne muscular dystrophy (2)
Earnings (1848)
Editorial (2)
Employer branding (1)
Employer resources (2)
Events (3330)
Executive appointments (52)
FDA (553)
Funding (98)
Gene editing (16)
Generative AI (2)
Gene therapy (12)
GLP-1 (19)
Government (314)
Guidances (5)
Healthcare (647)
HIV (1)
Huntington's disease (3)
Immunology and inflammation (7)
Immuno-oncology (3)
Infectious disease (269)
Inflammatory bowel disease (4)
Influenza (13)
Intellectual property (7)
Interviews (11)
IPO (409)
IRA (1)
Job creations (195)
Job search strategy (78)
Labor market (4)
Layoffs (16)
Leadership (4)
Legal (135)
Liver cancer (4)
Lung cancer (5)
Lymphoma (17)
Machine learning (1)
Manufacturing (35)
MASH (1)
Medical device (549)
Medtech (550)
Mergers & acquisitions (688)
Metabolic disorders (16)
Multiple sclerosis (2)
Neurodegenerative disease (5)
Neuroscience (73)
NextGen: Class of 2025 (270)
Non-profit (355)
Obesity (7)
Opinion (12)
Ovarian cancer (2)
Pain (5)
Pancreatic cancer (3)
Parkinson's disease (8)
Partnered (3)
Patents (14)
Patient recruitment (6)
Peanut (1)
People (4059)
Pharmaceutical (2)
Phase I (732)
Phase II (937)
Phase III (568)
Pipeline (76)
Policy (17)
Postmarket research (33)
Preclinical (415)
Press Release (23)
Prostate cancer (2)
Radiopharmaceuticals (4)
Rare diseases (20)
Real estate (402)
Recruiting (2)
Regulatory (697)
Reports (4)
Research institute (423)
Resumes & cover letters (11)
RSV (1)
Schizophrenia (1)
Series A (13)
Series B (9)
Service/supplier (1)
Sickle cell disease (2)
Spinal muscular atrophy (10)
Sponsored (1)
Startups (295)
Supply chain (6)
Tariffs (4)
The Weekly (1)
Vaccines (68)
Venture capital (4)
Weight loss (1)
Women's health (8)
Date
Today (1)
Last 7 days (11)
Last 30 days (74)
Last 365 days (939)
2025 (873)
2024 (1245)
2023 (1519)
2022 (2265)
2021 (2466)
2020 (2610)
2019 (2031)
2018 (1633)
2017 (1846)
2016 (1688)
2015 (1975)
2014 (1471)
2013 (1339)
2012 (1063)
2011 (1255)
2010 (1110)
Location
Africa (44)
Alabama (3)
Arizona (3)
Asia (1774)
Australia (323)
California (242)
Canada (117)
China (24)
Colorado (8)
Connecticut (9)
Delaware (2)
Europe (3552)
Florida (28)
Georgia (74)
Idaho (1)
Illinois (14)
Indiana (4)
Japan (4)
Kansas (7)
Louisiana (1)
Maine (2)
Maryland (36)
Massachusetts (200)
Michigan (7)
Minnesota (67)
Mississippi (2)
Missouri (13)
Montana (1)
New Hampshire (1)
New Jersey (102)
New Mexico (1)
New York (101)
North Carolina (35)
North Dakota (1)
Northern California (101)
Ohio (15)
Oregon (1)
Pennsylvania (80)
Rhode Island (8)
South America (51)
South Carolina (1)
Southern California (101)
Tennessee (7)
Texas (45)
United States (1142)
Utah (3)
Vermont (1)
Virginia (15)
Washington D.C. (5)
Washington State (24)
West Virginia (1)
Wisconsin (1)
30,495 Results for "tvax biomedical".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Capital Health Partnering with TVAX Biomedical to Offer Brain Cancer Immunotherapy Trial
July 8, 2024
·
4 min read
Business
Genelux Corporation and TVAX Biomedical, Inc. announce the issuance of a United States patent covering the combination of an adoptive T cell therapy/oncolytic viral cancer treatment that is exclusively licensed to V2ACT Therapeutics™, LLC
Genelux Corporation (NASDAQ: GNLX) and TVAX Biomedical, Inc. today announced that the United States Patent and Trademark Office granted a patent claiming methods of combining vaccine-enhanced adoptive T cell therapy with oncolytic virus adjunct therapy.
June 29, 2023
·
5 min read
Press Releases
QUEL Imaging and INO Announce Technology Transfer to Advance Biomedical Optics
November 19, 2025
·
4 min read
Press Releases
Lifecore Biomedical to Participate in Upcoming November 2025 Investor Conferences
November 11, 2025
·
1 min read
Press Releases
WCC Biomedical@NACDS Total Store Expo: Advancing Microneedle Drug Delivery With WINMAP™ Platform
August 11, 2025
·
3 min read
Press Releases
Lifecore Biomedical to Participate at Upcoming Industry Conferences and Events
October 13, 2025
·
2 min read
Press Releases
ABK Biomedical Raises US$35M in Series D Financing
October 15, 2025
·
3 min read
Press Releases
Lifecore Biomedical Selected as New Commercial Manufacturing Partner by Leading Global Pharmaceutical Company
October 29, 2025
·
5 min read
Press Releases
Ignite Biomedical and Liquid Biosciences Announce the Discovery of Biomarkers for the Diagnosis and Treatment of Autism Spectrum Disorder
November 5, 2025
·
6 min read
FDA
TVAX Biomedical announces major advancements in potential Glioblastoma cure
TVAX Biomedical (TVAX), is a cancer immunotherapy company that is moving into its pivotal glioblastoma study for FDA regulatory approval. TVAX Immunotherapy® could fundamentally change the way cancer is treated as T cells can kill all cancer cells, including cancer stem cells, without the toxicity of current treatments. With early
December 9, 2020
·
2 min read
1 of 3,050
Next
